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A bstract
The goal o f these experiments is to determine the relative effects o f various agents
(Ptpt dinucleotide, lutein, and vitamin C) on the activity o f long terminal repeat (LTR) in
HTV 1 infected cells (HIV LTR) in both control and UV exposed cells. It is known that
the LTR is important in transcription and therefore viral replication. A HeLa cell line
transfected with a plasmid that has the HTV-LTR and an E. coli chloranphenicol acetyl
transferase (CAT) reporter gene was used. The agents were applied and then the amount
o f CAT activity was measured doing a CAT assay. The more CAT activity means the
more LTR activity.
The results showed that none o f the agents used (ptpt dinucleotide, lutein, and
vitamin C) inconclusively inhibited the LTR in HIV 1 infected cells. This doesn’t mean
that these agent don’t have inhibitory elements. These experiments simply show that the
agent doesn’t inhibit the LTR directly or through NFkB. It may inhibit through another
enzymatic signal cascade or through a method other than the LTR. Another explanation
for the results are that the concentration was too low and/or the agent didn’t have enough
time to have an effect on the cells. Therefore, further experimentation is needed to
discount these agents as a possible HTV treatment.
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Introduction
Despite AIDS (acquired immunodeficiency syndrome) deaths going down in the
mid 1990s due to combination treatments that help keep other infections at bay, there are
about one million people in the United States infected with HIV (Boyles 2001). The
Center for Disease Control and Prevention (CDC) reported as o f June 30, 1997 AIDS is
the second leading killer o f people ages 25-44 in the United States with 612,078 cases o f
AIDS and 379,258 AIDS deaths. Worldwide the CDC reported an estimated 30.6 million
people were living with HTV/AIDS as o f December 1997. Through 1997 there have been
11.7 million (9 million adults and 2.7 million children) HTV/AIDS related deaths (National
Institute o f Allergy and Infectious Diseases 1998). AIDS is caused by HIV (human
immunodeficiency virus). The virus attacks and kills CD4+T cells o f the immune system,
and the death o f these immune cells leaves the host vulnerable to opportunistic infections.
The virus has two single strands o f RNA and at the ends o f these strands is an RNA
sequence called the long terminal repeat (LTR). This sequence controls the production o f
new viruses. The HIV-LTR is stimulated by the cellular trans-activator Nuclear Factor kB
(NFkB) and the viral protein Tat (Biswas et. al 1993).
The production o f new viruses can be triggered by many different stresses like
proteins in the virus or host cell. UV light is also known to be a stress that induces LTR
activity. In the following experiments UVC light (100-280 nm) was used. UVC is
absorbed by nucleic acids and proteins (Tyrell, 1996) and causes DNA damage. This kind
o f light doesn’t make to the earth’s surface (it is blocked by the ozone layer) but it is used
in all germicidal lamps found in labs, hospitals, etc. Valerie (1988) et al. report that UVC
does indeed induce HTV type 1 LTR in HeLa cells.. It is not known how UV induces
HIV-LTR but there are many theories.
UV light activates a variety o f transcription factors and proteins (Devary et al.,
1992; Sachsenmaier et al., 1994). One such transcription factor is NFkB (Devary et al.,
1993). It moves from the cytoplasm to the nucleus and binds to the DNA inducing LTR

activity. UVB can also induce this transcription sequence but most o f the following
experiments will be using UVC. These HeLa cells were transfected with a plasmid that
had the HTV-LTR and E. coli chloramphnicol acetyl tranferase (CAT) gene. Therefore
when LTR is activated so is the CAT reporter gene. So the amount o f LTR activity is
measured indirectly by finding the amount o f CAT activity. We obtained the HeLa cells
engineered by Valerie from Gayle Woloschak o f Argonne National Laboratory.

Materials and Methods
CAT assay: The media was poured off and the plates were rinsed once with cold PBS.
Then 3 ml o f trypsin was added to the plates and the cells were allowed to detach. 3 ml o f
PBS was then added and the suspension was put into 15 ml centrifuge tubes and put on
ice. The plates were then washed with 1 ml PBS and added to the tubes. The tubes were
centrifuged for 10 minutes at 1,000 rpm. The supernatant was discarded and 1 ml o f cold
PBS was added to the tubes. The supernatant was transferred to epindorf tubes. 0.1 ml
o f the supernatant was added to 10 ml o f PBS to count the number o f cells in a Coulter
Counter. The remaining liquid in the epindorf tube was centrifuged for five minutes. The
supernatant was removed and 150 ul o f 0.25 M Tris-HCl (pH 8.0) was added. The pellet
was resuspended and put through three freeze/thaw cycles using liquid nitrogen and a 37.0
degree Celsius water bath. The tubes were then heated in a 60 degree Celsius water bath
for ten minutes to inactivate the endogenous acetylase. The tubes were spun again for
four minutes. The supernatant was transferred to new tube and stored for 24 hours in a
-80 degree Celsius freezer. During this 24 hour period the master mix was made. This
contained 69.5 ul o f 0.25 M Tris-HCl (pH 8.0), 5 ul n-butyryl Coenzyme A, and 0.5 ul
3H-chloramphenicol (0.025 mCi/ml). After 24 hours the supernatant was thawed and 50
ul is added to a new epindorf tube. 80 ul o f the master mix was added under the
radioactive hood. The tubes were then incubated at 37 degrees Celsius for 2.0 hours.
Then 300 ul o f xylene was added to terminate the labeling. The tubes were then vortexed

vigorously for 1-2 minutes and spun for 3 minutes. The aqueous layer was removed and
150 ul o f 0.25 M Tris-HCl was added. The tubes were vortexed and spun as before. The
aqueous layer (lower layer) was again removed and another 150 ul o f Tris-HCl was added.
The tubes were vortexed and spun again as before. Next 200 ul o f the upper organic layer
was removed and added to a scintillation vial with 10 ml o f scintillation cocktail. A
scintillation counter was used to determine cpm and the results were plotted in counts per
100,000 cells.
Incubator: The incubator used was a water-saturated incubator at 37.2 degrees Celsius
and 2.5% C 02.

media: The media consisted o f Dulbecco’s modified Eagle’s medium (DMEM), 10% fetal
bovine serum, and antibiotics.

Chapter 1

The effect of ptpt dinucleotide on LTR in HIV 1 infected cells
Introduction: Ptpt thymidine dinucleotide has been shown to enhance DNA repair by
activating p53 (Maeda, et. al. 1999). p53 is a tumor suppressor protein and transcription
factor. Therefore it is hypothesized that since p53 inhibits transcription factor perhaps it
also inhibits the long terminal repeat in HTV 1 infected cells.

Materials and Methods: The cells used were HeLa cells transfected with the HTV-LTR
and CAT reporter gene on a plasmid. The cells were cultured in five plates at 300,000
cells per plate in 35 mm dishes. Each dish was given 5ml o f media. The cells were placed
in the incubator and allowed to attach. The plates were then exposed to various
procedures as shown in Table 1.

Table 1: Plate treatment #1 of dinucleotide Ptpt
plate number name

treatment

1

control

wash 2 times with 3 ml PBS and given 5 ml o f media

2

UVC

washed 2 times with 3 ml PBS and exposed to 19 J/m2 o f

-

UVC light and given 5 ml o f media
3

UVB

washed 2 times with 3 ml PBS and exposed to 200 J o f
UVB light and given 5 ml o f media

4

ptpt

add 55.5 ul ptpt (oligodeoxythymidylate) and 5 ml o f media

5

ptpt +pbs

washed 2 times with 3 ml PBS and add 55.5 ul ptpt and 5
.roLofonedla__________________________________________i

*the ptpt solution consisted o f 0.5 ml o f PBS and 50 units o f ptpt dinucleotide (ptt
oligodeoxythymidylate)

After this treatment the cells where again placed in the incubator for twenty-four hours.
After twenty-four hours the cells were put through a CAT assay to determine the amount
o f CAT activity present.
Then to verify the results the experiment was performed again with the treatments shown
in table 2 and then placed through a CAT assay. 400,000 cells were plated for each 35mm
dish. They were allowed to attach then put through the treatments shown below.

Table 2: Treatment #2 using ptpt on HIV infected HeLacells
plate number 'Name

Treatment

1

control

wash twice with 3 ml PBS and add 5 ml media

2

control UV

wash twice with 3 ml PBS, expose to 19 J/m2 UVC, and
add 5 ml media

3

ptpt #1

wash twice with 3 ml PBS and add 5 ml media and 55.5 ul
ptpt

4

ptpt #2

wash twice with 3 ml PBS and add 5 ml media and 55.5 ul
ptpt

Results: The results o f this experiment are shown in Tables 3 and 4 and Charts 1 and 2.
These results seen to contradict each other. Treatment #1 showed no decrease (and
actually a small increase) in LTR activity and Treatment #2 showed a decrease in LTR
activity.

Tabic .3; _CAT activity in HeLa Cells with Ptpt treatment #1
LTreatment__________ CAT activitv in counts/100,000 cells
Control

7,476.287

UVC

28,623.946

UVB

7,465.975

Ptpt dinucleotide

12,115.438

Ptpt and PBS wash

8,544.118
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Chart #1; CAT Activity in HeLa Cells with Ftpt Treatment #1

Table 4: CAT activity in treatment #2_HeLa Cells
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Chart #2: CAT activity in Treatment #2_HeLa Cells

control

control UV

Ptpt #1

Ptpt #2

Treatment

Discussion: The results for the ptpt dinucleotide were mixed. Treatment #1 showed that
ptpt didn’t inhibit HIV-LTR (in fact it showed a slight increase). Then treatment #2
showed that there was a slight inhibition o f HIV-LTR. However, there was an anomaly in
the second treatment. The cell count for the dishes treated with the ptpt was about double
that o f the control. This brings up the possibility of systematic error where perhaps the
Coulter Counter was miscalculating. If this is the case and there are actually fewer cells
on the plates treated with the ptpt then the numbers for the CAT activity is less than it
really is. Another interesting source o f error is that UVB in treatment #1 did not increase
the LTR activity. This could be due to the treatment being too low. However, this
doesn’t affect the results obtained.
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I f the results from treatment #1 is the case, this lack o f decrease (and slight
increase) in LTR activity could be due to many various reasons. One is that it indeed
doesn’t inhibit LTR. The other reason is that the ptpt inhibits LTR but indirectly through
a method other than NFkB. NFkB is a transcription factor (Devary et al., 1993) found in
the HeLa cells that when it is released by inhibitory kB (IkB) travels from the cytoplasm to
the nucleus where it binds to the DNA to induce transcription and therefore cell
proliferation. Perhaps it stimulates an enzyme that inhibits LTR not transfected into the
HeLa cell. The slight increase in CAT activity may be due to the possibility that ptpt
dinucleotide causes stress on the cell. And as mentioned before stresses on the cell cause
activation o f LTR. But regardless o f the effect o f ptpt, more experimentation is needed to
reach a true conclusion on its abilities.

W
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Chapter 2

The effect of lutein on LTR in HIV 1 infected cells
Introduction: It is known that oxidative stresses may be important for the progression o f
the HTV disease because it activates NFkB which is needed for HTV replication (Treitinger
et al. 2000). Therefore it is reasonable to think that antioxidants like lutein would slow
down HIV replication. In this experiment the effect o f lutein on HIV-LTR activity was
examined. It has been found that there are significant depletions o f carotenoids (like
lutein) in those infected with HIV (Lacey et al. 1996). So there is a metabolic change that
occurs in those affected with HTV. The body could be using carotenoids to try and fight
the disease. Another finding that supports this hypothesis is that low concentrations o f
plasma carotenoids were associated with increased risk o f death in infants with HTV
(Melikian et al. 2001). Chauvin (1999) showed that vitamin E, another antioxidant, was
shown to inhibit UV-induced CAT activity. It was hypothesized that this was due to its
antioxidant properties. Therefore it would be logical to assume lutein, a stronger
antioxidant, would have a greater inhibitory effect.

Materials and Methods: Six 35mm plates were plated with 503,040 cells per plate. The
cells were kept in an incubator and allowed to attach. Then the cells were exposed to the
treatments according to table 3.

Table 5: Lutein treatments #1
[Plate number Name

Treatment

1

control

wash 2 times with 3 ml PBS and add 5 ml media

2

control UV

wash 2 times with 3 ml PBS, expose to 19 J/m2 o f
UVC, and add 5 ml media

3

ethanol

wash 2 times with 3 ml PBS and add 5 ml media and 30ul
ethanol

4

ethanol UV

wash 2 times with 3 ml PBS, expose to 19 J/m2 o f UVC,
and add 5 ml media and 30ul ethanol

5

lutein

wash 2 times with 3 ml PBS and add 5 ml media and 30 ul
o f lutein/ethanol mixture*

6

lutein UV

wash 2 times with 3 ml PBS, expose to 30 seconds o f UVC,
and add 5 ml media and 30 ul o f lutein/ethanol mixture*

*The lutein/ethanol mixture composed o f 1 mg xanthophyll (lutein) and 0.439 ml
o f ethanol giving a concentration o f 2.27 mg/ml.
After twenty-four hours the cells were put through a CAT assay to determine the amount
o f CAT activity present.
Next, to test the effect o f a change in concentration and time to react, eight 35mm plates
were plated with 600,000 cells. These cells were placed in the incubator and allowed to
attach. They were then subjected to the treatments in table 6.

Table 6: Lutein treatments #2
Plate number name

treatment

1

control

wash twice with 3 ml PBS and add 5 ml media

2

control UV

wash twice with 3 ml PBS, expose to 19 J/m2 UVC, and
add 5 ml media

3

ethanol

wash twice with 3 ml PBS and add 5 ml media and 40 ul o f
ethanol

4

ethanol UV

wash twice with 3 ml PBS, expose to 19 J/m2 UVC, and
add 5 ml media and 40 ul ethanol

5

24 hour lutein wash twice with 3 ml PBS and add 5 ml media and 40 ul
lutein solution

6

24 hour lutein wash twice with 3 ml PBS, expose to 19 J/m2 UVC, and
UV

add 5 ml media and 40 ul lutein solution

16

48 hour lutein wash twice with 3 ml PBS and add 5 ml media and 40 ul

1

lutein solution
8

48 hour lutein wash twice with 3 ml PBS, expose to 19 J/m2 UVC, and
add 5 ml media and 40 ul lutein solution

UV

*The lutein/ethanol mixture composed o f 1 mg xanthophyll and 0.439 ml o f
ethanol giving a concentration o f 2.27 mg/ml.
**A11 cells were plated on the same day however plates 1-4 and 7-8 were treated
48 hours before the CAT assay and plates 5 and 6 were treated 24 hours before
the CAT assay

Results: Both treatments didn’t show a decrease in LTR activity in HIV 1 infected cells.
The results o f the first treatment are shown in table seven and chart three; and the second
treatment in table eight and chart four. Ethanol alone (plates 3 and 4) was used to test the
effect o f the solvent used for lutein on the results. As can be seen in the following charts,
the ethanol had no effect on the amount o f CAT activity.*

Table 7: CAT activity in HeLa cells with Treatment #1 of lutein
LTreatment

CAT activity (counts/100r000 cells!

Control

1,538.5

ethanol UV

7,557.272

lutein

18,728.395

lutein UV

38,653.846

*There was contamination in the control UV and ethanol treatments

Chart #3; CAT activity in HeLa cells with treatment #1 of lutein

control

ethanol UV

lutein

lutein UV

Treatment

Table 8; CAT activity in HeLa Cells with treatment #2 of lutein
Treatment

CAT activity (counts/100.000 cells')

Control

6,557.32

Control UV

54,688.74

ethanol

7,312.02

ethanol UV

37,001.76

24 hour lutein

8,934.46

24 hour lutein UV

35,768.45

48 hour lutein

7,44.88

48 hour lutein

66,806.14
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Chart #5; CAT Activity in HeLa Cells with treatment #2 of lutein

Treatment
**due to the light sensitivity of lutein, the plates treated with lutein were covered in a
paper towel to prevent light exposure.

Conclusion: It has been shown that antioxidant supplementation helped in oxidation
defense for those with HIV but there was no benefit in using high doses o f it (Batterham
et al. 2001). Therefore this can’t be a cure for HIV but it can slow the progression o f the
disease. The results o f treatment #1 did not decrease the amount o f LTR activity in HIV 1
infected HeLa cells (as seen in table five and chart two). This effect may have been due to
too little o f a concentration or not enough time for the lutein to affect the cellular output.
So in the second treatment I increased the lutein concentration and time of incubation.
The results o f this were similar to treatment one (as seen in table seven and chart number
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four). There was once again little effect on the LTR activity. It is doubtful that the lack
o f effect was due to a low concentration since an observation was the cells turned an
orangish color (the color o f lutein). This suggests that the cells were saturated with lutein.
These results are still o f interest because vitamin E has been shown to inhibit LTR
using the same methods (Chauvin 1999). It was thought that the effect o f vitamin E was
due to its antioxidant effects. However lutein is a stronger antioxidant than vitamin E.
This suggests that there is something else in vitamin E that prevents LTR activity. So this
experiment didn’t show that lutein inhibited LTR but more experimentation needs to be
done before it is discounted as useful therapy to those who are HIV infected. Just because
there is no effect o f lutein on HIV-LTR doesn’t mean that it isn’t an effective inhibitor o f
HIV progression.

Chapter 3

The effect of Vitamin C on the LTR of HIV 1 infected cells
Introduction: It is possible that the oxidative stress that is associated with HIV infection
might be important in the progression o f the disease because the reactive oxygen species
activates the nuclear transcription factor (NFkB) (Treitinger, et al 2000). Another reason
to believe this is that lower concentrations o f ascorbate (vitamin C) were found in HIV
infected patients (Treitinger, et al 2000; Lacey et al 1996). This could be perhaps the
body’s way to fight the disease and a deficiency o f vitamin C would speed up HTV
progression. It has been shown that EPC-K1 (a compound o f vitamin C and vitamin E)
decreases NF-kappaB activity more than vitamin C or vitamin E alone (Hirano, et al
1998). Therefore it is our hypothesis that vitamin C will inhibit HTV1-LTR activity.

Materials and Methods: The cells used were HeLa cells transfected with the HIV-LTR
and CAT reporter gene on a plasmid. The cells were cultured in four 35 mm plates at
600,000 cells per plate. Each dish was given 5 ml media. The cells were placed in the
incubator and allowed to attach. The plates were then exposed to the procedures shown
in table nine.

Table 9; Plate treatment for Vitamin C
Plate number name

Treatment

1

control

wash twice with 3 ml PBS and add 5 ml media

2

control UV

wash twice with 3 ml PBS, expose to 19 J/m2 UVC, and
add 5 ml media

3

Vit. C

wash twice with 3 ml PBS and add 5 ml media and 50ul
ascorbic acid solution*

4

Vit. C UV

wash twice with 3 ml PBS, expose to 19 J/m2 UVC, and
add 5 ml media and 50 ul ascorbic acid solution*
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*Ascorbic acid (vitamin C) solution is composed o f vitamin C dissolved in water with a
concentration o f 5 mg/ml.
After twenty-four hours the cells were put through a CAT assay to determine the amount
o f CAT activity present.
Then to test the variation o f concentration and effectiveness over time, ten 35 mm
plates were plated with 300,000 cells and placed in the incubator to attach. The cells were
then submitted to the treatments shown in table ten.

Table 10: Plate treatment #2 forVitaminC
Plate number name

Treatment

1

control

wash twice with 3 ml PBS

2

control UV

wash twice with 3 ml PBS, expose to 19 J/m2 UVC, and

96 hours

add 5 ml media

Vit. C

wash twice with 3 ml PBS and add 5 ml media and 55 ul o f

96 hours

Vitamin C solution.

Vit. C

wash twice with 3 ml PBS, expose to 19 J/m2 UVC, and

96 hours

add 5 ml media and 55 ul o f vitamin C solution

control UV

wash twice with 3 ml PBS, expose to 19 J/m2 UVC, and

72 hours

add 5 ml o f media

Vit. C

wash twice with 3 ml PBS and add 5 ml media and 55 ul o f

72 hours

vitamin C solution

Vit. C UV

wash twice with 3 ml PBS, expose to 19 J/m2 UVC, and

72 hours

add 5 ml media and 55 ul ascorbic acid solution

control UV

wash twice with 3 ml PBS, expose to 19 J/m2 UVC, and

48 hours

add 5 ml media

Vit. C

wash twice with 3 ml PBS and add 5 ml media and 55 ul

48 hours

ascorbic acid solution

3

W
4

5

6

7

8

9
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10

Vit. C UV

wash twice with 3 ml PBS, expose to 19 J/m2 UVC, and

48 hours

add 5 ml media and 55 ul ascorbic acid solution

Results: The results of this experiment were not as expected. The vitamin C did not
effectively inhibit the LTR in HIV 1 infected cells.
Table 11: CAT activity from vit. C treatment in HeLa cells

Chart 5; CAT activity in Vitamin C treated HeLa cells

70000
60000
50000
40000
30000
20000
10000

0
control

control UV

vitamin C

Treatment

vitamin C UV
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Table 12: CAT activity in HeLa cells treatm ent #2 with_yitaniiiL-C

W

Treatment

CAT activity (counts/ 100r000 cells)

control

14,299.17

control UV; 96 hours 90,976.89
Vit. C; 96 hours

58,195.83

Vit. C U V ;9 6 hours

153,198.53

control UV; 72 hours 85,823.17
Vit. C; 72 hours

116,492.28

Vit. C UV; 72 hours

♦

control UV; 48 hours 283,144.07
Vit. C; 48 hours

247,111.98

Vit. C UV; 48 hours

103,131.19

*These results had to be thrown out due a large amount o f cell death (so not enough cells
w

to count).

Chart #6: CAT activity in Vitamin C Treatment #2 in HeLa Cells

W

Treatment
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Discussion: These results were contrary to the hypothesis that vitamin C would inhibit the
HIV-LTR activity. As can be seen in tables 11 and 12 and charts five and six vitamin C
didn’t inhibit HIV-LTR activity. A possible reason for this is that the effects o f vitamin C
are long term. The previous tests were performed for only the effects o f four days. The
results also show in treatment #2 that the treatment actually increased the amount o f CAT
activity. This may be due to the increased concentration o f vitamin C caused a greater
effect o f its acidic properties (ascorbic acid). This acidic property may cause stress on the
cell activating the LTR. Therefore further experimentation is needed to determine the
effects o f ascorbic acid as a possible treatment for those with HIV.

W
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